Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
10
×
national blog main
national top stories
10
×
startups
10
×
biotech
boston top stories
life sciences
new york blog main
new york top stories
san francisco blog main
deals
san francisco top stories
cancer
boston
clinical trials
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
biogen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
indiana blog main
indiana top stories
investing
ipo
national
novartis
seattle blog main
seattle top stories
vc
wisconsin blog main
wisconsin top stories
aducanumab
alzheimer's disease
What
new
10
×
medicines
bio
drugs
roundup
adds
aims
biotech
developing
disease
drug
earlier
research
startup
therapeutics
activity
address
ago
aim
aiming
alliance
allosteric
ambys
announced
approach
approval
approvals
areas
backed
bails
based
big
biogen
biogen’s
biopharmaceutical
biosciences
bio’s
boost
brand
bridgebio
Language
unset
Current search:
new
×
startups
×
" boston blog main "
×
" national top stories "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?